| PERIOD ENDING | 31-Jan-09 | 31-Oct-08 | 31-Jul-08 | 30-Apr-08 | | Total Revenue | 3,097 | 3,296 | 3,739 | 3,661 | | Cost of Revenue | 467 | 716 | 3,349 | 802 | | | Gross Profit | 2,630 | 2,580 | 390 | 2,859 | | | Operating Expenses | | Research Development | 722 | 772 | 708 | 931 | | Selling General and Administrative | 2,136 | 2,196 | 2,654 | 3,397 | | Non Recurring |
-
| 276 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (228) | (664) | (2,972) | (1,469) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (131) | (213) | (175) | (555) | | Earnings Before Interest And Taxes | (354) | (884) | (3,146) | (2,024) | | Interest Expense | 44 | 45 | 925 |
-
| | Income Before Tax | (398) | (929) | (4,071) | (2,024) | | Income Tax Expense | 61 | 135 | (6) | 46 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (459) | (1,064) | (4,065) | (2,070) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (459) | (1,064) | (4,065) | (2,070) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($459) | ($1,064) | ($4,065) | ($2,070) |
|
0.22% Nasdaq 
0.02 (4.88%) 
Income Statement
